Folate-Responsive Neurologic Diseases

Pediatric Neurology

Volumn 37, Issue 6, 2007, Pages 387-397

  Djukic, Aleksandra ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FOLIC ACID; FOLINIC ACID; MYELIN; RNA; S ADENOSYLMETHIONINE;

AMINO ACID METABOLISM; COENZYME; DRUG SOLUBILITY; EARLY DIAGNOSIS; EMBRYO DEVELOPMENT; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GENE EXPRESSION REGULATION; HUMAN; MYELINATION; NEURAL TUBE DEFECT; NEUROLOGIC DISEASE; NEUROTRANSMITTER RELEASE; NUCLEIC ACID SYNTHESIS; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; REVIEW;

FOLIC ACID; HUMANS; NERVOUS SYSTEM DISEASES; VITAMIN B COMPLEX;

EID: 36049049394     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2007.09.001     Document Type: Review

References (95)

1. Lucock M. Folic acid: Nutritional biochemistry, molecular biology and role in disease processes. Mol Genet Metabol 71 (2000) 121-138
2. Gregory J.F. Folate bioavailability. J Nutr 131 Suppl. (2001) 1376S-1382S
3. Cuskelly C.J., Nulty H., and Scott J.M. Effect of increasing dietary folate on red-cell folate: Implications for prevention of neural tube defects. Lancet 47 (1996) 657-659
4. Blount B.C., Mack M.M., Wehr C.M., et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94 (1977) 3290-3295
5. Crott J., Sang-Woon C., Branda R., and Mason J. Accumulation of mitochondrial DNA deletions is age, tissue and folate dependent in rats. Mutat Res 570 (2005) 63-70
6. Kim Y.-I., Progribny I.P., and Basnakian A.G. Folate deficiency in rats induces DNA strand breaks and hypomethylation with the p53 tumor suppressor gene. Am J Clin Nutr 65 (1997) 46-52
7. Jacob R.A. Folate, DNA methylation and gene expression: Factors of nature and nurture. Am J Clin Nutr 72 (2000) 903-904
8. Phillip L., Pearl A., Philip K., et al. Inherited disorders of neurotransmitters in children and adults. Clin Biochem 38 (2005) 1051-1058
9. Rosenblatt D., and Fenton W.A. Inherited disorders of folate and cobalamin transport and metabolism. In: Scriver C.R., Beaudet A.L., and Sly W.S. (Eds). The metabolic and molecular bases of inherited disease. 8th ed (2001), McGraw-Hill, New York 3897-3933
10. Caballero M., and Hendrich B. MeCP2 in neurons: Closing in on the causes of Rett syndrome. Hum Mol Genet 14 (2005) 19-26
11. Hyland K., Smith I., Bottiglieri T., et al. Demyelination and decreased S-adenosylmethionine in 5,10-methylenetetrahydrofolate reductase deficiency. Neurology 38 (1988) 459-462
12. Kamath Tallur K., Johnson D., Kirk J., Sandercock P., and Minns R. Folate-induced reversal of leukoencephalopathy and intellectual decline in methylenetetrahydrofolate reductase deficiency: Variable response in siblings. Dev Med Child Neurol 47 (2005) 53-56
13. Fournier I., Ploye F., Cottet-Emard J., Brun J., and Claustrat B. Folate deficiency alters melatonin secretion in rats. J Nutr 132 (2002) 2781-2784
14. Hutto B.R. Folate and cobalamin in psychiatric illness. Compr Psychiatry 38 (1997) 305-314
15. US Department of Health and Human Services, Food and Drug Administration Food Standards. Amendment of the standards of identity for enriched grain products to require addition of folic acid. Fed Reg 61 (1996) 8781-8807
16. Surtees R. Cobalamin and folate responsive disorders. International review of child neurology series. In: Baxter P. (Ed). Vitamin responsive conditions in pediatric neurology (2001), MacKeith Press, London 96-109
17. Gregory J.F. Bio-availability of folate. Eur J Clin Nutr 51 (1997) 554-559
18. 12 interrelationships. Essays Biochem 28 (1994) 63-72
19. Ratanasthien K., Blair J.A., Leeming R.J., Cooke W.T., and Melikian V. Serum folates in man. J Clin Pathol 30 (1977) 438-448
20. Holm J., Hansen S.I., Hoier-Madsen M., and Bostad L. High affinity folate binding in human choroids plexus. Biochem J 280 (1991) 267-271
21. Henderson G.B. Folate-binding proteins. Annu Rev Nutr 10 (1990) 319-335
22. Fowler B. Genetic defects of cobalamin and folate metabolism. Eur J Pediatr 157 Suppl. (1988) S60-S66
23. Lucock M.D., Hartley R., and Smithells R.W. A rapid and specific HPLC-electrochemical method for the determination of endogenous 5-methyltetrahydrofolic acid in plasma using solid phase sample preparation with internal standardization. Biomed Chromatogr 3 (1989) 58-64
24. Ramaekers V., and Blau N. Cerebral folate deficiency. Dev Med Child Neurol 46 (2004) 843-851
25. Sabharanjak S., and Mayor S. Folate receptor endocytosis and trafficking. Adv Drug Deliv Rev 56 (2004) 1099-1109
26. Kamen B.A., and Smith A.K. New perspectives on folate catabolism. Ann Drug Deliv Rev 56 (2004) 1085-1097
27. Wu D., and Pardridge W.M. Blood-brain barrier transport of reduced folic acid. Pharm Res 16 (1999) 415-419
28. Lee H.C., Shoda R., Krall J.A., Foster I.D., Selhub J., and Rosenberry T.L. Folate binding protein from kidney brush border membranes contains components of a glycoinositol phospholipids anchor. Biochemistry 31 (1992) 3236-3243
29. Weitman S.D., Weinberg A.G., Coney L.R., Zurwski V.R., Jennings D.S., and Kamen B.A. Cellular localization of the folate receptor, potential role in drug toxicity and folate homeostasis. Cancer Res 52 (1992) 6708-6711
30. Birn H., Selhub J., and Christensen E.I. Internalisation and intracellular transport of folate-binding protein in rat kidney proximal tubule. Am J Physiol 264 (1993) 302-310
31. Spector R. Micronutrient homeostasis in mammalian brain and cerebrospinal fluid. J Neurochem 53 (1989) 1667-1674
32. Spector R., and Johanson C. Micronutrient and urate transport in choroid plexus and kindney: Implications for drug therapy. Pharm Res 23 (2006) 2515-2524
33. Wang Y., Zhao R., Russel R.G., and Goldman I.D. Localization of the murine reduced folate carrier as assessed by immunochistochemical analysis. Biochim Biophys Acta 1513 (2001) 49-54
34. Matthews R.G. Methionine biosynthesis. In: Blakley R.L., and Benkovic S.J. (Eds). Folates and pterins (1984), Wiley, New York 497-554
35. Green R., and Miller J. Folate deficiency beyond megaloblastic anemia: Hyperhomocysteinemia and other manifestations of dysfunctional folate status. Semin Hematol 36 (1999) 47-64
36. Ormarzabal A., Garcia-Cazorla A., Perez-Duenas B., et al. Determination of 5-methyltetrahydrofolate in cerebrospinal fluid of paediatric patients: Reference values for a paediatric population. Clin Chim Acta 371 (2006) 159-162
37. Ramaekers V.T., Haeusler M., Opladen T., Heimann G., and Blau N. Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: A novel neurometabolic condition responding to folinic acid substitution. Neuropediatrics 33 (2002) 301-308
38. Moretti P., Sahoo T., Hyland K., et al. Cerebral folate deficiency with developmental delay, autism, and response to folinic acid. Neurology 64 (2005) 1088-1090
39. Ramaekers V.T., Sheldon P., Rothenberg M.D., et al. Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N Engl J Med 352 (2005) 1985-1991
40. Svendsen I., Hansen S.I., Holm J., and Lyngbye J. Amino acid sequence homology between human and bovine low molecular weight folate binding protein isolated from milk. Carlsberg Res Commun 47 (1982) 371-376
41. Pineida M., Ormazabal A., Lopez-Gallardo E., et al. Cerebral folate deficiency and leucoencephalopathy caused by a mitochondrial DNA deletion. Ann Neurol 59 (2006) 394-398
42. Allen M.C.T., DiMauro S., and Coulter D. Kearns-Sayre syndrome with reduced plasma and cerebrospinal fluid folate. Ann Neurol 13 (1983) 679-681
43. Dougados M., Zittoun J., Laplane D., and Castaigne P. Folate metabolism disorder in Kearns-Sayre syndrome. Ann Neurol 13 (1983) 679-682
44. Tanji K., Schon E., Di Mauro S., and Bonilla E. Kearns-Sayre syndrome: Oncocytic transformation of choroids plexus epithelium. J Neurol Sci 178 (2000) 29-36
45. Ormazabal A., Artuch R., Vilaseca M.A., Aracil A., and Pineda M. Cerebrospinal fluid concentrations of folate biogenic amines and pterins in Rett syndrome: Treatment with folic acid. Neuropediatrics 6 (2005) 380-385
46. Ramaekers V., Hansen S.J., Holm J., et al. Reduced folate transport to the CNS in female Rett patients. Neurology 61 (2003) 506-514
47. Blau N., Bonafe L., Kragenlog-Mann I., et al. Cerebrospinal fluid pterins and folates in Aicardi-Goutieres syndrome: A new phenotype. Neurology 61 (2003) 642-647
48. Wevers R.A., Hansen S.I., van Hellenburg-Huber J.L., Holm J., Holer-Madsen M., and Jongen P.J. Folate deficiency in cerebrospinal fluid associated with a defect in folate binding protein in the central nervous system. J Neurol Neurosurg Psychiatry 57 (1994) 223-226
49. Hyland K., Buist N.R., Powel B.R., Hoffman G.F., Rating D., McGrath J., and Acworth I.N. Folinic acid responsive seizures: A new syndrome?. J Inherit Metab Dis 18 (1995) 177-181
50. Frye R.E., Donner E., Golja A., and Rooney C.M. Folinic acid responsive seizures presenting as breakthrough seizures in a 3 month old boy. J Child Neurol 18 (2003) 562-569
51. Torres O.A., Miller V.S., Buist N.M., and Hyland K. Folinic acid responsive neonatal seizures. J Child Neurol 14 (1999) 529-532
52. Nicolai J., van Kranen-Mastenbroek V., Wevers R.A., Hurkx W., and Vles J. Folinic acid responsive seizures initially responsive to pyridoxine. Pediatr Neurol 34 (2006) 164-167
53. Hyland K., and Arnold L.A. Value of lumbar puncture in the diagnosis of infantile epilepsy and folinic acid responsive seizures. J Child Neurol 17 Suppl (2002) S48-S55
54. Hyland K. Folinic acid responsive seizures. International review of child neurology series. In: Baxter P. (Ed). Vitamin responsive conditions in pediatric neurology (2001), MacKeith Press, London 54-61
55. Committee on Genetics, American Academy of Pediatrics. Folic acid for the prevention of neural tube defects. Pediatrics 104 (1999) 325-327
56. Bower C. Neural tube defects and childhood brain tumors: the role of maternal vitamin supplementation. International review of child neurology series. In: Baxter P. (Ed). Vitamin responsive conditions in pediatric neurology (2001), MacKeith Press, London 13-21
57. Wald N.J. Folic acid and the prevention of neural tube defects. N Engl J Med 350 (2004) 101-103
58. Maddox D.M., Manlapat A., Roon P., Prasad P., Ganapathy V., and Smith S.B. Reduced-folate carrier (RFC) is expressed in placenta and yolk sac, as well as in cells of the developing forebrain, hindbrain, neural tube, craniofacial region, eye, limb buds and heart. BMC Dev Biol 29 (2003) 1-8
59. Prasad P.D., Ramamoorthy S., Moe A.J., Smith C.H., Leibach F.H., and Ganapathy V. Selective expression of the high-affinity isoform of the FR (folate receptor) in the human placental syncytiotrophoblast and choriocarcinoma cells. Biochim Biophys Acta 1223 (1994) 71-75
60. De Marco P., Moroni A., Merello E., et al. Folate pathway gene alterations in patients with neural tube defects. Am J Med Genet 95 (2000) 216-223
61. Rothenberg S.P., da Costa M.P., Sequeira J.M., et al. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural tube defect. N Engl J Med 350 (2004) 134-142
62. Finnell R.H., Gelineau-van Waes J., Bennett G.D., et al. Genetic basis of susceptibility to environmentally induced neural tube defects. Ann NY Acad Sci 919 (2000) 216-277
63. van der Put N.M.J., van den Heuvel L.P., Steegers-Theunissen R.P.M., et al. Decreased methylene tetrahydrofolate reductase activity due to the 677C2.T mutation in families with spina bifida offspring. J Mol Med 74 (1998) 691-694
64. Botto L.D., and Yang Q. 5-10Methylentetrahydrofolate reductase variants and congenital anomalies: A HuGE review. Am J Epidemiol 151 (2000) 862-877
65. de Bree A., Verschuren W.M., Bjorke-Monsen A.L., et al. Effect of the methylenetetrahydrofolate reductase 677C3T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am J Clin Nutr 77 (2003) 687-693
66. Molloy A.M., Daly S., Mills J.L., et al. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: Implications for folate intake recommendations. Lancet 349 (1997) 1591-1593
67. Dean J., Moore J., Osborne A., Howe J., and Turnpenny P.D. Fetal anticonvulsant syndrome and mutation in the maternal MTHFR gene. Clin Genet 56 (1999) 216-220
68. Pippenger C.E. Pharmacology of neural tube defects. Epilepsia 44 (2003) 24-32
69. Kishi T., Fujita N., Eguchi T., and Ueda K. Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy. J Neurol Sci 145 (1997) 109-112
70. Smith D.B., and Carl G.F. Interactions between folates and carbamazepine or valproate in the rat. Neurology 32 (1982) 965-969
71. Brent L.B., Oakley G.P., and Mattison D.R. The unnecessary epidemic of folic acid-preventable spina bifida and anencephaly. Pediatrics 106 (2000) 825-827
72. American Academy of Pediatrics, Committee on Genetics. Folic acid for the prevention of neural tube defects. Pediatrics 104 (1999) 325-327
73. Baggot P.J., Eliseo A.J., Kalamarides J.A., and Shoemaker J.D. A folate-dependent metabolite in amniotic fluid from pregnancies with normal or trisomy 21 chromosomes. Fetal Diagn Ther 21 (2006) 148-152
74. Hobbs C.A., Sherman S.L., Yi P., et al. Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am J Hum Genet 67 (2000) 623-630
75. James S.J., Pogribna M., Pogribny I.P., et al. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase (MTHFR) gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 70 (1999) 495-501
76. O'Leary V.B., Arle-McDermott A., Molloy A.M., et al. MTRR and MTHFR polymorphisms: Link to Down syndrome?. Am J Med Genet 107 (2002) 151-155
77. Bosco P., Gueant-Rodri{dotless}guez R.M., Anello G., et al. Methionine synthase (MTR) 2756 (A-G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevate homocystinemia are three risk factors for having a child with Down syndrome. Am J Med Genet 121A (2003) 219-224
78. Singh R., Kumar M., and Raman P. MTHFR C677 and A1298C polymorphisms are risk factors for Down's syndrome in Indian mothers. J Hum Genet 51 (2006) 278-283
79. Pogribna M., Melnyk S., Pogribny I., Chango A., Yi P., and James S.J. Homocysteine metabolism in children with Down syndrome: In vitro modulation. Am J Hum Genet 69 (2001) 88-95
80. Marti{dotless}nez-Frias M.L., Perez B., Lourdes R., et al. Maternal polymorphisms 677C-T and 1298A-C of MTHFR, and 66A-G MTRR genes: Is there any relationship between polymorphisms of the folate pathway, maternal homocysteine levels, and the risk for having a child with Down syndrome?. Am J Med Genet 140 (2006) 987-997
81. Verkerk A.J., Pieretti M., and Sutcliffe J.S. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 5 (1991) 905-914
82. OMIM. 309548. Fragile site, folic acid type, rare, FRA(X) (q28); FRAXE, http://www.ncbi.nlm.nih.gov/entrez/dispomin.
83. Hirst M.C., Barnicoat A., Flynn G., et al. The identification of a third fragile site, FRAXF, in Xq27-q28 distal to both FRAXA and FRAXE. Hum Mol Genet 2 (1993) 197-200
84. Giraud F., Ayme S., Mattei J.F., and Mattei M.G. Constitutional chromosomal breakage. Hum Genet 34 (1976) 125-136
85. Dhur A., Galan P., and Herberg S. Folate status and the immune system. Prog Food Nutr Sci 15 (1991) 43-60
86. Nath B.J., and Lindebaum J. Persistence of neutrophil hypersegmentation during recovery from megaloblastic granulopoiesis. Ann Intern Med 90 (1979) 757-760
87. Zittoun J., and Zittoun R. Modern clinical testing strategies in cobalamin and folate deficiency. Semin Hematol 36 (1999) 35-46
88. Poncz M., Colman N., and Herbert V. Therapy of congenital folate malabsorption. Pediatrics 98 (1981) 76-79
89. Tonetti C., Sauduboray J.M., Echenne B., Landrieu P., Giraudier S., and Zittoun J. Relations between molecular and biological abnormalities in 11 families from siblings affected with methylenetetrahydrofolate reductase deficiency. Eur J Pediatr 162 (2003) 466-475
90. Burtscher A., Bories D., Tulliez M., and Zittoun J. Methylenetetrahydrofolate reductase deficiency in four siblings: A clinical, biochemical, and molecular study of the family. Am J Med Genet 91 (2000) 363-367
91. Ogier de Baulny H., Gerard M., Saudubray J.M., and Zittoun J. Remethylation defects: Guidelines for clinical diagnosis and treatment. Eur J Pediatr 157 Suppl. (1998) S77-S83
92. Haworth J.C., Dilling L.A., and Surtees R.A. Symptomatic and asymptomatic methylene-tetrahydrofolate reductase deficiency in two adult brothers. Am J Med Genet 45 (1993) 572-576
93. Pasquier F., Lebert F., and Petit H. Methylenetetrahydrofolate reductase deficiency revealed by a neuropathy in a psychotic adult. J Neurol Neurosurg Psychiatry 57 (1994) 765-766
94. Holme E., Kjellman B., and Ronge E. Betaine for treatment of homocystinuria caused by methylenetetrahydrofolate reductase deficiency. Arch Dis Child 64 (1989) 1061-1064
95. Ronge E., and Kjellman B. Long term treatment with betaine in methylenetetrahydrofolate reductase deficiency. Arch Dis Child 74 (1996) 239-241